In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate.
All Keywords
【저자키워드】 coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, SARS-CoV-2, vaccination, Neutralizing antibodies, COVID 19, Thailand, Inactivated SARS-CoV-2 vaccine, 【초록키워드】 neutralizing antibody, Vaccine, coronavirus, Neutralizing antibodies, CoronaVac, variants of concern, severe acute respiratory syndrome Coronavirus, variants, respiratory, Support, acute respiratory syndrome, serum samples, recipients, These data, recipient, serum sample, original virus strain, 【제목키워드】 titer, induced, Limited,
【저자키워드】 coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, SARS-CoV-2, vaccination, Neutralizing antibodies, COVID 19, Thailand, Inactivated SARS-CoV-2 vaccine, 【초록키워드】 neutralizing antibody, Vaccine, coronavirus, Neutralizing antibodies, CoronaVac, variants of concern, severe acute respiratory syndrome Coronavirus, variants, respiratory, Support, acute respiratory syndrome, serum samples, recipients, These data, recipient, serum sample, original virus strain, 【제목키워드】 titer, induced, Limited,
코로나백 백신 접종자의 혈청 샘플에서 유도된 중증 급성 호흡기 증후군 코로나바이러스 2 중화 항체의 시험관 내 측정은 원래 바이러스 균주에 대한 짧은 보호 기간과 우려되는 변이체에 대한 제한된 보호를 보여주었습니다. 이 데이터는 백신 부스터, 특히 유통되는 우려 변종에 대한 지원을 제공합니다.